» Articles » PMID: 16973543

Optimization of Feline Immunodeficiency Virus Vectors for RNA Interference

Overview
Journal J Virol
Date 2006 Sep 16
PMID 16973543
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

RNA interference (RNAi) occurs naturally in plant and animal cells as a means for modulating gene expression. This process has been experimentally manipulated to achieve targeted gene silencing in cells, tissues, and animals, using a variety of vector systems. Here, we tested the hypothesis that vectors based on feline immunodeficiency virus (FIV) could be used for coexpression of reporter constructs and RNAi expression cassettes. We found, unexpectedly, in our initial constructs that placement of RNAi expression cassettes downstream from a polymerase II (pol II)-expressed reporter gene inhibited reporter expression but not vector titer. Through a series of intermediate vector constructs, we found that placement of the RNAi expression cassette relative to the Rev response element and the pol II expression cassette was critical for efficient RNAi and reporter gene expression. These results suggested that steric factors, including RNA structure and recruitment of competing transcriptional machinery, may affect gene expression from FIV vectors. In a second series of studies, we show that target sequence silencing can be achieved in cells transduced by FIV vectors coexpressing reporter genes and 3' untranslated region resident microRNAs. The optimized FIV-based RNAi expression vectors will find broad use given the extensive tropism of pseudotyped FIV vectors for many cell types in vitro and in vivo.

Citing Articles

α-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Ca channel Ca1.2 activity and long-term potentiation in rodents.

Man K, Bartels P, Henderson P, Kim K, Shi M, Zhang M Elife. 2023; 12.

PMID: 37338965 PMC: 10325713. DOI: 10.7554/eLife.79648.


Recent advances in RNA interference therapeutics for CNS diseases.

Ramachandran P, Keiser M, Davidson B Neurotherapeutics. 2013; 10(3):473-85.

PMID: 23589092 PMC: 3701762. DOI: 10.1007/s13311-013-0183-8.


MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiation.

Fineberg S, Datta P, Stein C, Davidson B PLoS One. 2012; 7(6):e38562.

PMID: 22701667 PMC: 3372529. DOI: 10.1371/journal.pone.0038562.


Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases.

Garwick-Coppens S, Herman A, Harper S BMC Biotechnol. 2011; 11:107.

PMID: 22087765 PMC: 3252340. DOI: 10.1186/1472-6750-11-107.


RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).

Wallace L, Garwick-Coppens S, Tupler R, Harper S Mol Ther. 2011; 19(11):2048-54.

PMID: 21730972 PMC: 3222519. DOI: 10.1038/mt.2011.118.


References
1.
Miyagishi M, Sumimoto H, Miyoshi H, Kawakami Y, Taira K . Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells. J Gene Med. 2004; 6(7):715-23. DOI: 10.1002/jgm.556. View

2.
Wang Z, Ren L, Zhao X, Hung T, Meng A, Wang J . Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J Virol. 2004; 78(14):7523-7. PMC: 434119. DOI: 10.1128/JVI.78.14.7523-7527.2004. View

3.
Sumimoto H, Miyagishi M, Miyoshi H, Yamagata S, Shimizu A, Taira K . Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene. 2004; 23(36):6031-9. DOI: 10.1038/sj.onc.1207812. View

4.
Consiglio A, Gritti A, Dolcetta D, Follenzi A, Bordignon C, Gage F . Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc Natl Acad Sci U S A. 2004; 101(41):14835-40. PMC: 522006. DOI: 10.1073/pnas.0404180101. View

5.
Carbon P, Murgo S, Ebel J, Krol A, Tebb G, Mattaj L . A common octamer motif binding protein is involved in the transcription of U6 snRNA by RNA polymerase III and U2 snRNA by RNA polymerase II. Cell. 1987; 51(1):71-9. DOI: 10.1016/0092-8674(87)90011-0. View